In a recent development, L’Oreal has reached a resolution in the patent dispute brought forth by the University of Massachusetts and Carmel Laboratories regarding the use of adenosine in L’Oreal’s Revitalift moisturizer.
According to a report from Reuters, all involved parties have officially notified the Delaware federal court of the resolution, signaling the end of their legal dispute. The initial case asserted claims that L’Oreal had violated patents held by Carmel and the University of Massachusetts.
While specific details of the settlement remain undisclosed, neither L’Oreal nor the other parties involved have provided comments in response to a request for further information, as reported by Reuters.
